fda declaratory order semaglutide shortage resolved feb 21 2025 Says Ozempic, Wegovy US judge upholds FDA's removal

A class-action complaint filed in November 2025 against OpenLoop Health and Triad Rx - the medical group infrastructure and pharmacy involved in a separate telehealth platform - alleges that compounded oral tirzepatide tablets have no viable absorption pathway and therefore cannot produce a therapeutic effect

It has been demonstrated to help individuals lose and maintain weight loss over an extended period

Thinking about food isnt always unhealthy

Vincent AM, Russell JW, Low P, Feldman EL

Male participant (age 51) RESULTS: *The oxidative stress market F2-Isoprostane decreased by 55% in the first 14 days, maintaining a 52% decrease after 28 days

The pivotal STEP trials for semaglutide and SURMOUNT trials for tirzepatide included thousands of participants with monitoring for suicidal ideation using standardized tools such as the Columbia-Suicide Severity Rating Scale (C-SSRS), and did not demonstrate elevated rates compared to placebo groups